Search results for "Respiratory system"

showing 10 items of 1829 documents

Late Breaking Abstract - Predictive value of FeNO in patients with non-specific respiratory symptoms: a randomised controlled trial

2017

Background: Fractional exhaled nitric oxide (FeNO) can predict treatment response in asthma, but little is known of its utility in patients with non-specific respiratory symptoms (NSRS). Aims and objectives: To evaluate the association between baseline FeNO and response to treatment with inhaled corticosteroids (ICS) in patients with NSRS. Methods: This was a multi-centre randomised, placebo-controlled trial, carried out in UK and Singapore. It consisted of a 2-week assessment period to establish baseline measurements and a 4-week treatment period with either extrafine ICS (200 µ beclomethasone bid) or placebo. NIOX VERO (Circassia) was used to measure baseline FeNO. The primary endpoint wa…

medicine.medical_specialtybusiness.industryPlacebomedicine.diseaseConfidence intervallaw.inventionRandomized controlled triallawAsthma Control QuestionnaireInternal medicineExhaled nitric oxidemedicineClinical endpointRespiratory systembusinessAsthmaGeneral Practice and Primary Care
researchProduct

Editorial commentary: Sleep disordered breathing and cardiovascular outcomes: is it time to change our thinking?

2017

no abstract

medicine.medical_specialtybusiness.industryPolysomnographySleep apnea030204 cardiovascular system & hematologySettore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.diseaseCardiovascular Systemlaw.inventionSleep apnea Cardiovascular outcomes Randomized controlled trial03 medical and health sciences0302 clinical medicineSleep Apnea Syndromes030228 respiratory systemRandomized controlled triallawSleep disordered breathingPhysical therapyMedicineHumansCardiology and Cardiovascular MedicinebusinessIntensive care medicineCardiovascular outcomes
researchProduct

Severe Chronic Allergic (and Related) Diseases: A Uniform Approach – A MeDALL – GA<sup>2</sup>LEN – ARIA Position Paper

2012

Concepts of disease severity, activity, control and responsiveness to treatment are linked but different. Severity refers to the loss of function of the organs induced by the disease process or to the occurrence of severe acute exacerbations. Severity may vary over time and needs regular follow-up. Control is the degree to which therapy goals are currently met. These concepts have evolved over time for asthma in guidelines, task forces or consensus meetings. The aim of this paper is to generalize the approach of the uniform definition of severe asthma presented to WHO for chronic allergic and associated diseases (rhinitis, chronic rhinosinusitis, chronic urticaria and atopic dermatitis) in …

medicine.medical_specialtybusiness.industryPublic healthImmunologymacromolecular substancesGeneral MedicineAtopic dermatitismedicine.disease3. Good health03 medical and health sciences0302 clinical medicine030228 respiratory systemDisease severityEpidemiologyImmunologymedicinePhysical therapyImmunology and AllergyPosition paperDisease process030212 general & internal medicineIntensive care medicinebusinessChronic urticariaAsthmaInternational Archives of Allergy and Immunology
researchProduct

Urinary diversion and reconstruction.

2000

Orthotopic bladder augmentation and substitution has been established as the standard procedure for urinary diversion in many institutions, with current studies reporting mainly on continence rates and procedure-associated complications, such as the risk of impairment of neobladder function by local tumor recurrences in the small pelvis. Similarly, in other types of continent diversion, such as continent cutaneous diversion and rectal reservoirs, current interest is primarily directed towards minimization of surgery-associated complications.

medicine.medical_specialtybusiness.industryUrologymedicine.medical_treatmentUrinary diversionUrinary BladderUrinary Reservoirs ContinentUrinary Bladder Diseasesrespiratory systemPlastic Surgery ProceduresUrinary DiversionSmall pelvisStandard procedureSurgeryUrodynamicsPostoperative ComplicationsUrinary IncontinenceUreter surgeryBladder augmentationMedicineHumansUreterbusinesshuman activitiesCurrent opinion in urology
researchProduct

Biomarkers in Community-Acquired Pneumonia (Cardiac and Non-Cardiac)

2020

Community-acquired pneumonia (CAP) remains the first cause of morbidity and mortality worldwide due to infection. Several aspects such as severity and host response are related to its clinical course and outcome. Beyond the acute implications that the infection provokes in the host, pneumonia also has long-term negative consequences. Among them, cardiovascular complications and mortality are the most outstanding. Therefore, an adequate recognition and stratification of the risk of complications and mortality is crucial. Many biomarkers have been studied for these reasons, considering that each biomarker mirrors a different aspect. Moreover, the clinical application of many of them is still …

medicine.medical_specialtybusiness.industrycardiaccardiovascularlcsh:RClinical courseHost responsebiomarkerslcsh:MedicineGeneral MedicineDiseaseReviewmedicine.disease03 medical and health sciencesPneumonia0302 clinical medicine030228 respiratory systemCommunity-acquired pneumoniamedicineBiomarker (medicine)pneumonia030212 general & internal medicinebusinessIntensive care medicineJournal of Clinical Medicine
researchProduct

Mometasone furoate delivered via Breezhaler and Twisthaler in patients with asthma

2019

Introduction: Mometasone furoate (MF), an inhaled corticosteroid (ICS), is approved for the treatment of asthma. Previous studies suggest that MF Twisthaler® doses of 800 and 200 µg and MF Breezhaler® doses of 320 and 80 µg would elicit similar lung function effects, respectively. These MF doses are also used in an indacaterol/MF combination in development for asthma. Since sensitivity to ICS is variable, individual patients’ ICS sensitivity (as measured by FEV1 decline on ICS weaning) was used to build a robust analysis model for the study data. Methods: This was a randomized, double-blind, double-dummy, parallel-group, non-inferiority study of 739 adolescents and adults with asthma. MF wa…

medicine.medical_specialtybusiness.industrymedicine.drug_classUrologyMometasone furoatemedicine.diseaseDermatologyMean difference03 medical and health sciences0302 clinical medicine030228 respiratory systemMedicineIndacaterolCorticosteroidIn patient030212 general & internal medicinebusinessRobust analysisLung functionmedicine.drugAsthmaAirway pharmacology and treatment
researchProduct

The Vortex model: A different approach to the difficult airway

2018

Airway management is an essential area in anaesthesia, and anaesthesiologists are considered the most expert professionals to manage airway tasks. However, complications related to inadequate airway management remain the most frequent cause of morbidity and mortality. Algorithmic strategy to solve difficulties fails, due to several factors related to its structure and clinical application. The Vortex Approach has emerged as a response to the limitations found in the algorithmic strategy of managing the difficult airway, by using a cognitive aid strategy to reduce cognitive load and fixation error. This new strategy may represent a solution to the elusive problem of the challenging airway an…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentCognitionGeneral Medicinerespiratory system03 medical and health sciences0302 clinical medicine030202 anesthesiologymedicineAirway management030212 general & internal medicineAirwaybusinessIntensive care medicineDifficult airwayCognitive loadRevista Española de Anestesiología y Reanimación (English Edition)
researchProduct

Chronisch thromboembolische pulmonale Hypertonie: Empfehlungen der Kölner Konsensus Konferenz 2016

2016

The 2015 European Guidelines on Pulmonary Hypertension did not cover only pulmonary arterial hypertension (PAH), but also other significant subgroups of pulmonary hypertension (PH). In June 2016, a Consensus Conference organized by the PH working groups of the German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK) was held in Cologne, Germany to discuss open and controversial issues surrounding the practical implementation of the European Guidelines. Several working groups were initiated, one of which was dedicated to the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (CTEPH). In ev…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentConsensus conference610 Medicine & health2700 General MedicineGeneral Medicine030204 cardiovascular system & hematologymedicine.diseasePulmonary hypertension3. Good healthPulmonary endarterectomy03 medical and health sciences0302 clinical medicinePharmacotherapy030228 respiratory systemAngioplastymedicine.arteryPulmonary arterymedicineChronic thromboembolic pulmonary hypertension10178 Clinic for PneumologyIntensive care medicinebusinessPediatric cardiologyDMW - Deutsche Medizinische Wochenschrift
researchProduct

AIRWAY MANAGEMENT IN TRAUMA PATIENTS

1999

Complications related to airway management in traumatized patients are common and, because of the importance and vulnerability of the ventilatory system, can be life threatening within a very short time. 25,39,48 Therefore, airway management is perhaps the most vital component in the treatment of traumatized patients. Patients who have suffered major trauma can present the most complex airway management problems, especially in the prehospital setting. 19 Because the treatment is time-critical, the evaluation of injuries is usually incomplete at the time airway management is undertaken. If the airway is injured, attempts to secure the airway by performing endotracheal intubation or insertion…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentMajor traumaTracheal intubationVulnerabilityEndotracheal intubationrespiratory systemmedicine.diseaseAnesthesiology and Pain MedicinemedicineAirway managementMedical emergencyAirwayIntensive care medicinebusinessAnesthesiology Clinics of North America
researchProduct

Synthesis of the Data on COVID-19 Skin Manifestations: Underlying Mechanisms and Potential Outcomes

2021

Abstract The incidence of coronavirus disease 2019 (COVID-19)-related skin manifestations has progressively grown, in parallel with the global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreading. The available evidence indicates that cutaneous signs are heterogeneous and can be divided as follows: a) erythematous rashes, b) lesions of vascular origin, c) vesicular rashes, d) urticarial rashes, and e) acute generalized exanthematous pustulosis (AGEP), erythema multiforme (EM) and other polymorphic/atypical reactions. Most cutaneous manifestations appear simultaneously or after respiratory and/or systemic symptoms such as fever, even if rarely urticaria has been reported as…

medicine.medical_specialtycutaneous manifestationscutaneous manifestationbusiness.industrySARS-CoV-2COVID-19DermatologyDiseaseReviewmedicine.diseaseAcute generalized exanthematous pustulosisDermatologyVirusHypersensitivity reactionImmune systemmedicineskin rashesErythema multiformeRespiratory systemChilblainsbusiness
researchProduct